BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16395493)

  • 1. [Confronting the practice of surgery on differentiated thyroid cancer with current guidelines in Germany. A multicenter trial].
    Schwab R; Wieler H; Birtel S; Ostwald-Lenz E; Kaiser KP; Becker HP
    Nuklearmedizin; 2005; 44(5):185-91. PubMed ID: 16395493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [One stage thyroidectomy and bilateral neck dissection for well-differentiated thyroid carcinoma].
    Pan YF; Zhang XH; Ye GH; Lin BR; Chen XM; Jia XJ; Zhou SM; Wang OC
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):389-92. PubMed ID: 17045009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the biology and optimal treatment for papillary microcarcinoma of the thyroid?
    Cheema Y; Olson S; Elson D; Chen H
    J Surg Res; 2006 Aug; 134(2):160-2. PubMed ID: 16780882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
    Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
    Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surgery and referral for subsequent 131I therapy for patients with differentiated thyroid carcinoma in the south-east of the Netherlands, 1983-1996, compared to the consensus guidelines from 1987].
    Kuijpens JL; Hoekstra OS; Hamming JF; Haak HR; Ribot JG; Coebergh JW
    Ned Tijdschr Geneeskd; 2002 Mar; 146(10):473-7. PubMed ID: 11913113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
    Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
    Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
    Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
    J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Total thyroidectomy of choice in papillary microcarcinoma].
    Pisello F; Geraci G; Sciumè C; Li Volsi F; Modica G
    G Chir; 2007; 28(1-2):13-9. PubMed ID: 17313727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus.
    Demidchik YE; Demidchik EP; Reiners C; Biko J; Mine M; Saenko VA; Yamashita S
    Ann Surg; 2006 Apr; 243(4):525-32. PubMed ID: 16552205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
    Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
    Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgery and follow-up 131I therapy in patients with differentiated thyroid carcinoma in the south-east of the Netherlands, 1983-1996, compliance with the 1987 consensus guidelines: additional data].
    Kuijpens JL; Verheij CD; Haak HR; Ribot JG; Hoekstra OS; Coebergh JW
    Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1835-6. PubMed ID: 15495514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
    Grigsby PW; Reddy RM; Moley JF; Hall BL
    Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity?
    Alvarado R; Sywak MS; Delbridge L; Sidhu SB
    Surgery; 2009 May; 145(5):514-8. PubMed ID: 19375610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas.
    Lin JD; Chao TC; Hsueh C
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):224-8. PubMed ID: 17223992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective surgery and adjuvant therapy based on risk classifications of well-differentiated thyroid cancer.
    Cross S; Wei JP; Kim S; Brams DM
    J Surg Oncol; 2006 Dec; 94(8):678-82. PubMed ID: 17131414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rate of multifocality and occult lymph node metastases in papillary thyroid carcinoma arising in thyroglossal duct cysts.
    Hartl DM; Al Ghuzlan A; Chami L; Leboulleux S; Schlumberger M; Travagli JP
    Ann Surg Oncol; 2009 Sep; 16(9):2595-601. PubMed ID: 19565286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery of lymph nodes in papillary thyroid cancer.
    Dionigi G; Dionigi R; Bartalena L; Boni L; Rovera F; Villa F
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1217-29. PubMed ID: 17020456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.